Navigation Links
Elite Skier Uses OmniPod(R) Insulin Management System at World Championships
Date:2/18/2009

Kris Freeman Joins Growing Ranks of Professional Athletes Who Use the OmniPod System to Manage their Diabetes

BEDFORD, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Kris Freeman, one of the country's top professional cross-country skiers, is competing on behalf of the US in the Skiing World Championships this month. As a world-class athlete, Freeman intends to medal, but he has already faced a more daunting challenger: Type I diabetes. Diabetes doesn't keep Freeman from performing at the top of his sport, thanks in part to the OmniPod(R) Insulin Management System, a revolutionary insulin infusion system with no tubing.

"As a professional athlete, I can't afford to worry about my diabetes when I'm competing, and with the OmniPod, I don't have to," said Freeman. "The OmniPod's innovative, tubing-free design is durable enough for the toughest conditions I face during competition. And off the slopes, it gives me freedom to live an active, healthy life, while maintaining great control of my diabetes."

Freeman, the number one Nordic distance skier in the United States, is already a twelve-time national champion, three-time Olympian, and the second most successful American cross-country skier of all time. In 2003, less than three years after his diagnosis with diabetes, Freeman became the first American to ever win the Under 23 World Championships and followed that success with a fourth place finish in the Cross-Country World Championships. In 2004, Freeman finished sixth and fifth in two consecutive World Cups, the best finish by an American in 20 years, and became the first American ever to be ranked in the top 20.

Freeman isn't the only professional athlete to enjoy the freedom of the OmniPod System and its innovative design. Other top athletes who use the OmniPod include:

  • Triathlete Jay Hewitt
  • Mountaineer Lisa Seaman
  • Team Type 1, a team of professional cyclists who have diabetes
  • Dolphin Trainer Robyn Cox

About the OmniPod Insulin Management System

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod - a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager - a wireless, menu-driven, hand-held device that programs the Pod.

About Insulet Corporation

Insulet Corporation (Nasdaq: PODD) is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Contact:

    Rachel Kessler, Lazar Partners
    (917) 660-0608


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Oscars, Parties Spur Cosmetic Surgery Quick Fixes with Hollywoods Elite...
2. Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft
3. Elitemeetings.com Wins Bronze in HSMAI'S Annual Adrian Awards Competition
4. Elite Meetings International Names New Advisory Board
5. EliteMeetings.com Announces Commission-Free Policy Comprehensive Search and RFP Engine Now Provides Net Rates for Groups
6. MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States
7. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
8. UAB joins elite brain cancer research group
9. Injury Patterns Similar for Circus Artists, Elite Athletes
10. China Yingxia International, Inc. Retains CCG Elite
11. Dynatronics Introduces New Synergie Elite Aesthetic Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health ... partnership to prep patients for colonoscopy at the HyGIeaCare® Center that is to ... Miami, FL. , The HyGIeaCare® Prep, cleared by the U.S. Food ...
(Date:3/24/2017)... ... 2017 , ... “Finding Christ Through Social Media: Year One ... the writer’s path toward true communion with God. “Finding Christ Through Social Media: ... creation of published author Lea Michelle Johnson, a follower of Christ, wife and ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... ... 23, 2017 , ... A recent report from the National Council on Teacher ... NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at 221 ... the U.S. It argues that this higher bar should be set by states, by ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... Road in Building 2. The clinic is the group’s second in New Braunfels and ... the company’s second New Braunfels location brings things full circle for the group, “It’s ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, ... advanced medical technology for non-invasive surgery, announced today ... System for treatment of uterine fibroids throughout the ... had received approval from the US Food and ... the Mirabilis System in the United States.  The ...
Breaking Medicine Technology: